Acadia Healthcare Company, Inc. (ACHC) — Financial statements
Income statement, balance sheet, and cash flow for Acadia Healthcare Company, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3,313↑5.0% | 3,154↑7.7% | 2,929↑12.2% | 2,610↑12.8% | 2,314 | |
| Cost of Revenue | 2,729↑11.8% | 2,442↑8.7% | 2,246↑2141.6% | 100↑10.5% | 91 | |
| Gross Profit | 583↓18.1% | 712↑4.3% | 683↓72.8% | 2,510↑12.9% | 2,224 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 195↑3.0% | 190↑7.8% | 176↓89.0% | 1,597↑12.5% | 1,419 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 195↑3.0% | 190↑7.8% | 176↓89.0% | 1,597↑12.5% | 1,419 | |
| Other Expenses | 0.00 | 0.00 | 0.00↓100.0% | 446↑14.2% | 390 | |
| Operating Expenses | 195↑3.0% | 190↑7.8% | 176↓91.4% | 2,043↑12.9% | 1,809 | |
| Total Costs & Expenses | 2,925↑11.1% | 2,632↑8.7% | 2,422↑13.0% | 2,143↑12.8% | 1,900 | |
| Operating Results | ||||||
| Operating Income | 388↓25.7% | 522↑3.1% | 507↑8.3% | 468↑12.8% | 414 | |
| Depreciation & Amortization | 189↑26.5% | 150↑13.0% | 132↑12.4% | 118↑10.4% | 107 | |
| EBITDA | -738↓221.4% | 608↑221.4% | 189↓66.3% | 562↑22.2% | 459 | |
| EBIT | -927↓302.3% | 458↑707.3% | 57↓87.2% | 444↑25.8% | 353 | |
| Interest & Other Income | ||||||
| Net Interest Income | -139↓19.3% | -116↓41.7% | -82↓17.7% | -70↑9.4% | -77 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 139↑19.3% | 116↑41.7% | 82↑17.7% | 70↓9.4% | 77 | |
| Non-Operating Income | 1,315↑1953.8% | 64↓85.8% | 450↑1790.7% | 24↓61.5% | 62 | |
| Other Income / Expenses | -1,454↓705.9% | -180↑66.1% | -532↓468.6% | -94↑32.6% | -139 | |
| Income Before Tax | -1,066↓411.8% | 342↑1448.1% | -25↓106.8% | 374↑35.7% | 276 | |
| Income Tax Expense | 26↓66.4% | 77↑898.0% | -10↓110.3% | 94↑39.3% | 68 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -1,092↓512.9% | 264↑1788.8% | -16↓105.6% | 280↑34.5% | 208 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -13 | |
| Net Income | -1,103↓531.4% | 256↑1279.7% | -22↓107.9% | 273↑43.3% | 191 | |
| Bottom-Line Net Income | -1,103↓531.4% | 256↑1279.7% | -22↓107.9% | 273↑43.3% | 191 | |
| EPS (Basic) | -12.16↓535.8% | 2.79↑1262.5% | -0.24↓107.9% | 3.05↑41.9% | 2.15 | |
| EPS (Diluted) | -12.16↓537.4% | 2.78↑1258.3% | -0.24↓108.1% | 2.98↑41.9% | 2.10 | |
| Weighted Average Shares | 91↓1.0% | 92↑0.7% | 91↑1.4% | 90↑1.0% | 89 | |
| Weighted Average Diluted Shares | 91↓1.5% | 92↑1.2% | 91↓0.7% | 92↑0.8% | 91 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.